EC Pharma
Active Risk: not assessedSummary
EC Pharma is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.
Articles of association
What the company does
- Name clauseThe name the company operates under according to its articles.
- EC Pharma
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “9000 Gent, Veldstraat 66” (deed in Dutch)“Vlaams Gewest” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Bestuursorgaan, 1” (deed in Dutch)
Meetings and financial year
- Financial yearThe twelve-month period the company draws up its annual accounts for.
- From 1 July to 30 June
- First financial yearThe first financial year after incorporation can be shorter or longer than twelve months.
- First financial year to 30-06-2027, first annual accounts due by 31-01-2028
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- The first on 15-12-2027 at 20:00
Oversight and winding up
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Bestuurder(s) in functie indien geen andere vereffenaar benoemd, ontbinding en sluiting vereffening in één akte mogelijk mits naleving…” (deed in Dutch)